n,n-dimethylarginine has been researched along with Hyperlipidemias in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Hsu, CP; Kou, YR; Lee, TS; Lu, TM; Zhao, JF | 1 |
| Fülöp, P; Harangi, M; Katkó, M; Lőrincz, H; Paragh, G; Seres, I; Szentpéteri, A; Varga, VE; Zsíros, N | 1 |
| Bekpınar, S; Çevik, A; Genc, S; Gürdöl, F; Küskü-Kiraz, Z; Olgaç, V; Ünlücerci, Y; Uysal, M | 1 |
| Chandrasekharan, UM; Elaine Husni, M; Hazen, SL; Wang, S; Wang, Z; Wilson Tang, WH; Wu, Y | 1 |
| Biberoglu, G; Hasanoğlu, A; Kasapkara, A; Kasapkara, ÇS; Tümer, L | 1 |
| Akturk, E; Altas, Y; Atas, H; Balta, S; Can, C; Demirkol, S; Erdem, K; Korkmaz, H; Kurtoglu, E; Sincer, I; Yilmaz, M | 1 |
| Feng, M; He, ZM; Lei, YP; Lin, Y; Lu, CW; Xiong, Y | 1 |
| Atabey, N; Demir, O; Demir, T; Durmus, N; Esen, A; Evcim, S; Gidener, S; Irer, B; Kahraman, E; Soner, BC; Toylu, A | 1 |
| Azqueta, M; Cases, A; Coll, E; Collado, S; Cruzado, JM; de la Torre, B; Deulofeu, R; Guerrero, L; Nicolau, C; Pons, M; Vera, M | 1 |
| Zoccali, C | 1 |
| Böger, RH; Cooke, JP; Vallance, P | 1 |
| Ritz, E | 1 |
| Bode-Böger, SM; Dierkes, J; Luley, C; Martens-Lobenhoffer, J; Westphal, S | 1 |
| Li, NS; Li, YJ; Liu, GZ; Xiong, Y; Yu, XJ | 1 |
2 review(s) available for n,n-dimethylarginine and Hyperlipidemias
| Article | Year |
|---|---|
[Cardiovascular events in chronic advanced renal insufficiency. Current concepts].
Topics: Anemia; Arginine; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Inflammation; Kidney Failure, Chronic; Nitric Oxide Synthase; Risk Factors; Sleep Apnea Syndromes; Smoking | 2003 |
Atherosclerosis in dialyzed patients.
Topics: Anemia; Animals; Arginine; Arteriosclerosis; Biomarkers; Cause of Death; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Europe; Humans; Hyperlipidemias; Hypertension; Inflammation; Kidney Failure, Chronic; Mice; Mice, Knockout; Nitric Oxide; Phosphates; Renal Dialysis | 2004 |
2 trial(s) available for n,n-dimethylarginine and Hyperlipidemias
| Article | Year |
|---|---|
Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
Topics: Arginine; Atorvastatin; Biomarkers; Coronary Angiography; Coronary Stenosis; Down-Regulation; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome; Turkey | 2014 |
Fenofibrate increases the L-arginine:ADMA ratio by increase of L-arginine concentration but has no effect on ADMA concentration.
Topics: Adult; Arginine; Biomarkers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fenofibrate; Follow-Up Studies; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
10 other study(ies) available for n,n-dimethylarginine and Hyperlipidemias
| Article | Year |
|---|---|
The detrimental effect of asymmetric dimethylarginine on cholesterol efflux of macrophage foam cells: Role of the NOX/ROS signaling.
Topics: Amidohydrolases; Animals; Arginine; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Cholesterol; Cytokines; Enzyme Inhibitors; Foam Cells; Hyperlipidemias; Lipoproteins, LDL; Macrophages; Male; Mice; Mice, Knockout, ApoE; NADPH Oxidase 1; Reactive Oxygen Species; Triglycerides | 2019 |
Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia.
Topics: Adult; Aged; Arginine; Aryldialkylphosphatase; Biomarkers; C-Reactive Protein; Case-Control Studies; CD40 Ligand; Female; Humans; Hyperlipidemias; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Middle Aged; Overweight; Peroxidase; Predictive Value of Tests; Vascular Cell Adhesion Molecule-1 | 2017 |
Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet.
Topics: Animals; Arginine; Atherosclerosis; Betaine; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Dietary Supplements; Fatty Liver; Guinea Pigs; Hyperlipidemias; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine; Nitric Oxide; Tyrosine | 2018 |
Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Topics: Aged; Arginase; Arginine; Arthritis, Rheumatoid; Biomarkers; Cardiovascular Diseases; Comorbidity; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prevalence; Risk Factors; United States | 2018 |
Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I.
Topics: Adolescent; Arginine; Child; Child, Preschool; Fatty Acids; Female; Glycogen Storage Disease Type I; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Peroxidation; Male | 2013 |
Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
Topics: Amidohydrolases; Animals; Arginine; Captopril; Diet, High-Fat; Endothelium, Vascular; Enzyme Inhibitors; Hyperlipidemias; Male; Rabbits | 2017 |
Time-course changes of nLDL-induced erectile dysfunction.
Topics: Animals; Arginine; Disease Models, Animal; Endothelium, Vascular; Erectile Dysfunction; Hyperlipidemias; Lipoproteins, LDL; Male; Nitric Oxide Synthase Type III; Rats, Wistar; Time Factors | 2017 |
[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Proteins; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Hyperhomocysteinemia; Hyperlipidemias; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Risk Factors; Smoking; Stroke Volume; Ultrasonography; Uremia | 2010 |
Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Homeostasis; Humans; Hyperhomocysteinemia; Hyperlipidemias; Nitric Oxide Synthase; Vasodilation | 2003 |
Endogenous inhibitors of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits.
Topics: Animals; Aorta, Thoracic; Arginine; Hyperlipidemias; Lipid Peroxidation; Male; Malondialdehyde; Nitric Oxide; Rabbits; Vasodilation; Vitamin E | 1996 |